This study will explore the effect of warfarin gene polymorphism on the effectiveness and
safety of anticoagulant therapy in patients with acute ischemic stroke, and clarify the
correlation between genetic testing and compliance rate of INR value. It will illustrate the
significance of gene-guided warfarin for administered dose to anticoagulation therapy in
patients with acute ischemic stroke. Then it will establish and verify a warfarin stable dose
prediction model suitable for such patients, and provide basis for the personalized
medication regimen of warfarin in patients with acute ischemic stroke.
Phase:
N/A
Details
Lead Sponsor:
First Affiliated Hospital Xi'an Jiaotong University